Author:
Bergamaschi Mateus M,Queiroz Regina Helena Costa,Chagas Marcos Hortes Nisihara,de Oliveira Danielle Chaves Gomes,De Martinis Bruno Spinosa,Kapczinski Flávio,Quevedo João,Roesler Rafael,Schröder Nadja,Nardi Antonio E,Martín-Santos Rocio,Hallak Jaime Eduardo Cecílio,Zuardi Antonio Waldo,Crippa José Alexandre S
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference45 articles.
1. Agurell S, Carlsson S, Lindgren JE, Ohlsson A, Gillespie H, Hollister L (1981). Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography. Experientia 37: 1090–1092.
2. Agurell S, Halldin M, Lindgren JE, Ohlsson A, Widman M, Gillespie H et al (1986). Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol Rev 38: 21–43.
3. Blanco C, Antia SX, Liebowitz MR (2002). Pharmacotherapy of social anxiety disorder. Biol Psychiatry 51: 109–120.
4. Borgwardt SJ, Allen P, Bhattacharyya S, Fusar-Poli P, Crippa JA, Seal ML et al (2008). Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition. Biol Psychiatry 64: 966–973.
5. Brunello N, den Boer JA, Judd LL, Kasper S, Kelsey JE, Lader M et al (2000). Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment. J Affect Disord 60: 61–74.
Cited by
593 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献